German Remedies, Dr Falk Pharma Ink Marketing Pact

German Remedies, the Rs 143-crore pharma company has signed a licensing agreement with Dr Falk Pharma GmbH of Germany to make and market their products in India.

Company sources said two major products would be launched in the gastro-intestinal and hepetological categories in the next 18 months, but they refused to disclose other details.

Dr Falk Pharma is a privately owned German company with sales turnover of DM 100 million and was founded by Dr Herbert Falk.

With a strong presence in hepetological and gastro-intestinal products, the company exports to over 45 countries. German Remedies itself has a significant presence in gastrointestinals, respiratory products, oncologicals, hormones and radiology products. Thus, the alliance will complement its existing portfolio.

Sources at German Remedies said the company expects the new alliance to contribute significantly to its turnover. According to industry sources, the company is also looking at more tie-ups and investments in other companies for expanding its product portfolio. German Remedies recently started commercial production of some oncologicals at its Goa plant, which have been licensed to it by the principal collaborator, Asta Medica.

Earlier, Knoll AG had terminated its licensing arrangement with German Remedies after setting up a wholly-owned subsidiary in the country As a result, three products went back to Knoll, leading to a reduction in the latters basket.

The shareholding pattern at German Remedies has been undergoing a change, with Nordwark Arzeimittel having divested its shareholding and Beecham Wulfing having sold 95,251 shares to Asta Medica. Asta now has a seven per cent holding in the company.